OROBOROS (U.S. Trademark Serial Number 88723015) is a United States trademark of ORNA THERAPEUTICS, INC.. The goods and services include: Pharmaceuticals for the treatment of cancer, autoimmune, immune mediated, and inflammatory diseases and disorders, a full line of nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics Scientific research in the fields of nucleic acid pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics . The correspondent is Gwenn Roos of OnsideCounsel/Law Office of Gwenn Roos.

This trademark was filed on December 11, 2019 as United States Trademark Application Serial Number 88723015. This trademark application is still pending and does not yet have a registration number.

Trademark PTO Status History

July 04, 2022 – ABANDONMENT – NO USE STATEMENT FILED

February 10, 2022 – NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

February 09, 2022 – SOU EXTENSION 3 GRANTED

December 02, 2021 – SOU EXTENSION 3 FILED

February 07, 2022 – CASE ASSIGNED TO INTENT TO USE PARALEGAL

January 04, 2022 – NOTICE OF REVIVAL – E-MAILED

January 03, 2022 – EXTENSION RECEIVED WITH TEAS PETITION

January 03, 2022 – PETITION TO REVIVE-GRANTED

View full trademark status information at USPTO

Ownership History

ORNA THERAPEUTICS, INC.

Oroboros, Inc.

Oroboros, Inc.

View documents on file at USPTO

File a Trademark or Get Help With Trademark Law

Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.